Medication Formulation Affects Quality of Life: A Randomized Single-Blind Study of Clobetasol Propionate Foam 0.05% Compared With a Combined Program of Clobetasol Cream 0.05% and Solution 0.05% for the Treatment of Psoriasis

Article Type
Article
Changed
Thu, 01/10/2019 - 12:00
Display Headline
Medication Formulation Affects Quality of Life: A Randomized Single-Blind Study of Clobetasol Propionate Foam 0.05% Compared With a Combined Program of Clobetasol Cream 0.05% and Solution 0.05% for the Treatment of Psoriasis
Author(s)
Bergstrom KG
Arambula K
Kimball AB

Article PDF
072050407.pdf
Author and Disclosure Information

Kendra Gail Bergstrom, MD; Karina Arambula, BA; Alexa Boer Kimball, MD, MPH

Issue
Cutis - 72(5)
Publications
Cutis
MDedge Dermatology
Page Number
407-411
Sections
Original Research
Author(s)
Bergstrom KG
Arambula K
Kimball AB
Author(s)
Bergstrom KG
Arambula K
Kimball AB
Author and Disclosure Information

Kendra Gail Bergstrom, MD; Karina Arambula, BA; Alexa Boer Kimball, MD, MPH

Author and Disclosure Information

Kendra Gail Bergstrom, MD; Karina Arambula, BA; Alexa Boer Kimball, MD, MPH

Article PDF
072050407.pdf
Article PDF
072050407.pdf

Issue
Cutis - 72(5)
Issue
Cutis - 72(5)
Page Number
407-411
Page Number
407-411
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Article Type
Article
Display Headline
Medication Formulation Affects Quality of Life: A Randomized Single-Blind Study of Clobetasol Propionate Foam 0.05% Compared With a Combined Program of Clobetasol Cream 0.05% and Solution 0.05% for the Treatment of Psoriasis
Display Headline
Medication Formulation Affects Quality of Life: A Randomized Single-Blind Study of Clobetasol Propionate Foam 0.05% Compared With a Combined Program of Clobetasol Cream 0.05% and Solution 0.05% for the Treatment of Psoriasis
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Kimball AB